Trade SERA stock anytime, 24x5 in Singapore
Regulated by
Monetary Authority of Singapore (MAS)
Trusted by
400,000+ users
Sera Prognostics, Inc. Class A (SERA) is trading at US$2.09, up 0.72% today as of Sep 18, 16:00 EDT. The company has a market capitalisation of US$84.42M. Over the past 52 weeks, SERA has traded between US$1.56 and US$3.95. On Syfe you can trade SERA with $0 commission and add it to your watchlist.
| Previous close | US$2.07 |
|---|---|
| Market cap | US$84.42M |
| 52-week range | US$1.56 – US$3.95 |
| Volume | 92.09K |
| Exchange | US |
Add to Watchlist
Set Price Alert
Sera Prognostics, Inc. Class A
Sera Prognostics, Inc. engages in the provision of personalized diagnostics to predict and manage pregnancy complications. It focuses on developing blood tests to predict the risks of preterm birth, preeclampsia and other pregnancy complications. The company was founded by Steven W. Graves, Dennis Farrar and M. Sean Esplin in 2008 and is headquartered in Salt Lake City, UT.
Year: 2021
Sera Prognostics Names Scott Gleason as CFO
Aug 19, 9:00 PM · MT Newswires
--Craig-Hallum Initiates Sera Prognostics at Buy With $6 Price Target
Jun 4, 11:28 AM · MT Newswires
Sera Prognostics, Inc. Class A (SERA) stock is trading at US$2.09, +0.72% from the previous close of US$2.07.
The market cap for Sera Prognostics, Inc. Class A (SERA) stock is approximately US$84.42M.
The 52-week high for Sera Prognostics, Inc. Class A (SERA) stock is US$3.95.
The 52-week low for Sera Prognostics, Inc. Class A (SERA) stock is US$1.56.
Sera Prognostics, Inc. Class A (SERA) does not currently pay a dividend.
Stay on top of SERA
Price moves, news and earnings — straight to your inbox.
Est. order value
US$0.00
Snapshot
Popular Stocks in Singapore
